LER occurs when a known amount of endotoxin is "masked" or becomes undetectable by traditional Limulus Amebocyte Lysate (LAL) tests. This usually happens in products containing specific combinations of buffers and polysorbates (surfactants). The danger? A product could pass safety tests while still containing pyrogenic material that could harm a patient. Key Takeaways from TR 82
TR 82 adapts standard microbiological lethality calculations (F₀ concepts) to water system sanitization. It posits that if the temperature is maintained for a sufficient duration, microbial reduction is achieved.
For decades, safety testing for injectable drugs relied on a standard test to detect endotoxins—toxic components of bacteria that can cause life-threatening fevers. Scientists would "spike" a drug sample with a known amount of endotoxin to prove their test could find it. pda technical report 82
For those needing to perform these specialized studies, laboratories like Microcoat and bioMérieux offer dedicated based on TR 82 guidelines. Technical Report No. 82 "Low Endotoxin Recovery"
Assessing how quickly the internal temperature recovers after routine door openings or inventory audits. LER occurs when a known amount of endotoxin
Low Endotoxin Recovery is a phenomenon where the biological activity of environmental (natural) endotoxin is not detected over time when a product is spiked with a known amount of control standard endotoxin (CSE) or natural occurring endotoxin (NOE). It is important to note that LER is not caused by the breakdown or degradation of the lipopolysaccharide (LPS) molecule, but rather a masking phenomenon where the LPS forms aggregates, preventing the Limulus Amebocyte Lysate (LAL) reagents from detecting it.
By following the guidance provided in PDA Technical Report 82, pharmaceutical manufacturers can ensure that their products meet the required standards for solid content, extractables, and leachables. A product could pass safety tests while still
While TR 82 is groundbreaking, it has limitations:
: Unlike standard assay inhibition or enhancement, LER cannot be overcome by simply diluting the sample. The endotoxin structure is physically altered, rendering it invisible to routine compendial Bacterial Endotoxin Testing (BET), such as the Limulus Amebocyte Lysate (LAL) assay, despite potentially remaining biologically active. The Molecular Mechanism of Endotoxin Masking